/Charles%20River%20Laboratories%20International%20Inc_%20logo-%20by%20IgorGolovniov%20via%20Shutterstock.jpg)
Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) is a contract research organization. Valued at $12 billion by market cap, the company operates through Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions segments. CRL is expected to announce its Q2 earnings before the market opens on Wednesday, Aug. 7.
Ahead of the event, analysts expect Charles River to report a profit of $2.39 per share, down 11.2% from $2.69 per share reported in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS projections over the past four quarters. CRL reported an EPS of $2.27 in Q1 2024, exceeding the consensus estimates by 10.7%.